Literature DB >> 11009211

Neuronal intranuclear inclusion disease and juvenile parkinsonism.

J D O'Sullivan1, H A Hanagasi, S E Daniel, P Tidswell, S W Davies, A J Lees.   

Abstract

Juvenile parkinsonism (onset age <20 yrs) is uncommon and few cases with neuropathologic confirmation have been reported. We present the case of a 17-year-old boy who presented with asymmetric arm tremor and bulbar symptoms. His paternal great aunt had parkinsonism with onset at age 22 years. Examination revealed parkinsonism in the absence of additional neurologic signs except for delayed pupillary responses to light. He responded well to levodopa but developed motor fluctuations and disabling dyskinesias after 3 years of treatment. Following attempted withdrawal of levodopa at age 24 years, he developed severe aspiration pneumonia complicated by cardiorepiratory arrests and he died 6 months later. At autopsy, the dominant histologic feature was wide-spread neuronal hyaline intranuclear inclusions. Neuronal depletion was observed in the substantia nigra, locus ceruleus, and, to a lesser extent, in the frontal cortex, and inclusions were particularly prominent in these areas. Inclusions were immunoreactive for ubiquitin and were typical of those seen in neuronal intranuclear inclusion disease (NIID), a rare, multisytem neurodegenerative disease. NIID should be considered in the differential diagnosis of juvenile parkinsonism. A link between NIID and hereditary neurodegenerative disorders characterized by expanded polyglutamine tracts is supported by the similar appearance of intranuclear inclusions in both conditions and by a family history in some cases of NIID.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009211     DOI: 10.1002/1531-8257(200009)15:5<990::aid-mds1035>3.0.co;2-i

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

2.  Neuronal Intranuclear Inclusion Disease: Longitudinal Case Report of Motor and Nonmotor Symptoms.

Authors:  Jennifer Vermilion; Mahlon Johnson; Jayasri Srinivasan; Jonathan W Mink
Journal:  J Child Neurol       Date:  2019-07-15       Impact factor: 1.987

3.  Neuronal intranuclear inclusion disease presenting with resting tremor.

Authors:  Naoyuki Kitagawa; Jun Sone; Gen Sobue; Masahiko Kuroda; Michio Sakurai
Journal:  Case Rep Neurol       Date:  2014-05-28

4.  Clinicopathological features of adult-onset neuronal intranuclear inclusion disease.

Authors:  Jun Sone; Keiko Mori; Tomonori Inagaki; Ryu Katsumata; Shinnosuke Takagi; Satoshi Yokoi; Kunihiko Araki; Toshiyasu Kato; Tomohiko Nakamura; Haruki Koike; Hiroshi Takashima; Akihiro Hashiguchi; Yutaka Kohno; Takashi Kurashige; Masaru Kuriyama; Yoshihisa Takiyama; Mai Tsuchiya; Naoyuki Kitagawa; Michi Kawamoto; Hajime Yoshimura; Yutaka Suto; Hiroyuki Nakayasu; Naoko Uehara; Hiroshi Sugiyama; Makoto Takahashi; Norito Kokubun; Takuya Konno; Masahisa Katsuno; Fumiaki Tanaka; Yasushi Iwasaki; Mari Yoshida; Gen Sobue
Journal:  Brain       Date:  2016-10-25       Impact factor: 13.501

5.  Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders.

Authors:  Yun Tian; Jun-Ling Wang; Wen Huang; Sheng Zeng; Bin Jiao; Zhen Liu; Zhao Chen; Yujing Li; Ying Wang; Hao-Xuan Min; Xue-Jing Wang; Yong You; Ru-Xu Zhang; Xiao-Yu Chen; Fang Yi; Ya-Fang Zhou; Hong-Yu Long; Chao-Jun Zhou; Xuan Hou; Jun-Pu Wang; Bin Xie; Fan Liang; Zhuan-Yi Yang; Qi-Ying Sun; Emily G Allen; Andrew Mark Shafik; Ha Eun Kong; Ji-Feng Guo; Xin-Xiang Yan; Zheng-Mao Hu; Kun Xia; Hong Jiang; Hong-Wei Xu; Ran-Hui Duan; Peng Jin; Bei-Sha Tang; Lu Shen
Journal:  Am J Hum Genet       Date:  2019-06-06       Impact factor: 11.025

6.  CGG expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy with neurological manifestations.

Authors:  Masashi Ogasawara; Aritoshi Iida; Theerawat Kumutpongpanich; Ayami Ozaki; Yasushi Oya; Hirofumi Konishi; Akinori Nakamura; Ryuta Abe; Hiroshi Takai; Ritsuko Hanajima; Hiroshi Doi; Fumiaki Tanaka; Hisayoshi Nakamura; Ikuya Nonaka; Zhaoxia Wang; Shinichiro Hayashi; Satoru Noguchi; Ichizo Nishino
Journal:  Acta Neuropathol Commun       Date:  2020-11-25       Impact factor: 7.801

Review 7.  Clinical and mechanism advances of neuronal intranuclear inclusion disease.

Authors:  Yueqi Liu; Hao Li; Xuan Liu; Bin Wang; Hao Yang; Bo Wan; Miao Sun; Xingshun Xu
Journal:  Front Aging Neurosci       Date:  2022-09-13       Impact factor: 5.702

8.  Neuronal intranuclear inclusion disease is genetically heterogeneous.

Authors:  Zhongbo Chen; Wai Yan Yau; Zane Jaunmuktane; Arianna Tucci; Prasanth Sivakumar; Sarah A Gagliano Taliun; Chris Turner; Stephanie Efthymiou; Kristina Ibáñez; Roisin Sullivan; Farah Bibi; Alkyoni Athanasiou-Fragkouli; Thomas Bourinaris; David Zhang; Tamas Revesz; Tammaryn Lashley; Michael DeTure; Dennis W Dickson; Keith A Josephs; Ellen Gelpi; Gabor G Kovacs; Glenda Halliday; Dominic B Rowe; Ian Blair; Pentti J Tienari; Anu Suomalainen; Nick C Fox; Nicholas W Wood; Andrew J Lees; Matti J Haltia; John Hardy; Mina Ryten; Jana Vandrovcova; Henry Houlden
Journal:  Ann Clin Transl Neurol       Date:  2020-08-10       Impact factor: 4.511

9.  Reply to: No evidence supports genetic heterogeneity of neuronal intranuclear inclusion disease.

Authors:  Zhongbo Chen; Mina Ryten; Henry Houlden
Journal:  Ann Clin Transl Neurol       Date:  2020-10-30       Impact factor: 5.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.